美國眼科處方藥、儀器、診斷、手術用設備市場

美國眼科處方藥、儀器、診斷、手術用設備市場 是由出版商BCC Research在2006年09月所出版的。 這份英文市場調查報告書包含144 pages 42 tables 價格從美金4850起跳。

簡介

目錄

Abstract

INTRODUCTION

The aging of the population in the United States will result in a two-fold increase in the 65 and over population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. Additionally, current market competitors will endure pressure from the industry to continually provide advances in therapies and equipment and to compete with emerging competitors, who focus significantly on unmet needs of the ophthalmic consumer, including treatments for back of the eye conditions. The industry is likely to experience a burst of new products and heavy competition as the U.S. ophthalmic market advances.

SCOPE OF STUDY

This report contains:

• A thorough evaluation of the U.S. prescription ophthalmic pharmaceutical, device, diagnostic, and surgical market, with forecasts to 2011
• Market analysis focused on specific diseases and conditions such as cataract, glaucoma and refractive treatments
• Information regarding incidence and prevalence of eye conditions and risk factors associated with those conditions
• Examination of research and development activities with an emphasis on segments offering benefits to aging populations
• Profiles of the major companies in the industry as well as a detailed patent analysis.

METHODOLOGY

The information for this BCC report was obtained through primary and secondary data collection methods. Primary methods included interviews with key executives, product managers, and clinical specialists involved in the ophthalmic drug industry. Secondary methods included published literature in the area of ophthalmic drugs, investment reports, company literature, and various medical and business journals.

All market data pertains the U.S. market at the manufacturers' level. Data is expressed in current U.S. dollars. The base year of the report is 2006, with historical data provided for 2004 and 2005 and forecast data provided for 2011. Historical, base year, and forecast data is provided for each market segment of the report. Competitor market shares are provided for each market segment for the 2006 base year.

Table of Contents

• INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE AND FORMAT
  • ANALYST CREDENTIALS
  • DISCLAIMER
• SUMMARY
  • Summary Table:
  • U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
  • Summary Figure:
  • U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
• INDUSTRY OVERVIEW
  • VISION
    • STRUCTURE OF THE EYE
    • PATHOLOGY
  • POPULATION GROWTH AND DEMOGRAPHICS
  • Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
  • Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
    • OPHTHALMIC CONDITIONS AND DISEASES
      • DIABETIC RETINOPATHY
      • AGE-RELATED MACULAR DEGENERATION
      • OCULAR ALLERGIES
      • HERPES SIMPLEX VIRUS KERATITIS
      • CYTOMEGALOVIRUS RETINITIS
      • CATARACTS
      • GLAUCOMA
  • Table 2 GLAUCOMA TYPES AND KEY POINTS
    • UVEITIS
  • Table 3 KNOWN CAUSES OF UVEITIS
    • TRACHOMA
    • RETINAL DETACHMENT
    • DRY EYE SYNDROME
    • STRABISMUS
  • Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
    • OCULAR MUSCLE SPASMS
      • ISSUES AFFECTING THE MARKET
    • LITIGATION
      • The FDA' s Precautions Involving LASIK Eye Surgery
    • OPHTHALMIC PHARMACEUTICAL AND DEVICE COUNTERFEITING
    • OPHTHALMIC PHARMACEUTICAL/DEVICE RECALLS AND LABEL UPDATES
  • Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
    • GOVERNMENT INTERACTION
  • Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR MANUFACTURERS
    • S. 2480: CONTACT LENS CONSUMER PROTECTION ACT
    • S. 172
    • FAIRNESS TO CONTACT LENS CONSUMERS ACT
  • ADVERTISING
  • Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED STATES FOR 2005 ($)
    • PHARMACEUTICAL SIDE EFFECTS AND OPHTHALMIC CONDITIONS
  • Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
• PRODUCT MARKETS
  • PRESCRIPTION OPHTHALMIC PHARMACEUTICALS
    • PRODUCT DESCRIPTIONS
      • Anti-Inflammatory Drugs
  • Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY MANUFACTURER AND FDA APPROVAL DATE
    • Research and Development
    • Anti-Infectives
  • Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER AND DEVELOPMENT PHASE, 2006
    • Antihistamines and Mast Cell Stabilizers
  • Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
    • Beta- Adrenergic Blockers
  • Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA APPROVAL DATE
    • Research and Development
  • Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
    • Prostaglandins
  • Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
    • Other Pharmaceutical Treatments
      • Carbonic Anhydrase Inhibitors
      • Dry Eye Treatments
    • Miotics
      • Mydriatics and Cycloplegics
      • Ocular Anesthetics
        • Ocular Muscle Spasm Treatments
        • Pain Management Treatments
        • Vasoconstrictors
        • Other Treatments
  • Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
    • RESEARCH AND DEVELOPMENT
  • Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
    • MARKET SIZE AND GROWTH
  • Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (PERCENT/ $ MILLION)
  • Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (%)
  • Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURER REVENUES, 2006 ($ MILLION)
  • Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURERS REVENUES, 2006 (%)
    • OPHTHALMIC DIAGNOSTICS
      • PRODUCT DESCRIPTIONS
        • Visual Acuity Test
        • Dilated Eye Exam
        • Manifest Refraction
        • Pupil Reflex
        • Tonometry Test
        • Ophthalmoscopy
        • Gonioscopy
        • Slit Lamp Examinations
        • Fluorescein Staining
        • Eye Muscle Tests
        • Corneal Thickness
        • Pachymetry
        • Echography
        • Imaging Diagnostics
          • Optic Nerve Imaging
          • Optic Nerve Computer Imaging
          • Aberrometer
          • Innovative Imaging, Inc. and Echography
          • Corneal Topography
          • Flourescein Angiography
          • Slit-Lamp Photography
  • Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
    • Specular Microscopy
    • Glaucoma-Scope
    • Fundus Cameras
      • MARKET SIZE AND GROWTH
  • Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
  • Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
  • Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
  • Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%)
    • VISION CORRECTION AND VISION PRESERVATION DEVICES
      • PRODUCT DESCRIPTIONS
        • Soft (Disposable) Lenses
        • Gas Permeable Lenses
        • Cosmetic Lenses
        • Shaping Lenses
      • MARKET SIZE AND GROWTH
  • Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011 ($ MILLION)
  • Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
  • Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (PERCENT/ $ MILLION)
  • Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (%)
    • SURGICAL EQUIPMENT
      • PRODUCT DESCRIPTIONS
        • Corneal Procedures
          • Intracorneal Rings
          • Cornea Transplants (Penetrating keratoplasty)
          • Deep Anterior Lamellar Corneal Transplant (DLEK)
          • DSEK (Descemet' s Stripping with Endothelial Keratoplasty)
        • Lens Procedures
          • Verisyse Lens Implant
          • Lens Replacements
        • Refractive Procedures
          • Mechanical Microkeratome
          • Blade-Free Microkeratome
          • Lasek, LASIK, and PRK
        • Retinal Procedures
          • Vitreo-Retinal Surgery
        • Surgical Procedures for Cataracts
          • Phacoemulsification Cataract Surgery
          • Endocapsular Tension Ring
  • Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
    • Surgical Procedures for Glaucoma
      • Glaucoma Implant
      • Neodymium: YAG Laser Cyclophotocoagulation (YAG CP)
      • Diode Laser Transscleral Cyclophotocoagulation (Diode CYC)
      • Selective Laser Trabeculoplasty (SLT)
      • Argon Laser Trabeculoplasty (ALT)
      • Laser Peripheral Iridotomy (LPI)
      • Filtering Microsurgery
    • Procedures for Age-Related Macular Degeneration (AMD)
      • Focal Laser Treatment and PDT
    • Ophthalmic Lasers
      • Blade-Free Femtosecond Microkeratome
  • Table 29 MICROKERATOME/ FEMTOSECOND SYSTEMS BY MANUFACTURER
    • Excimer Laser
  • Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
    • Nd: Yag Lasers
  • Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
    • Other Laser Systems
      • Intraocular Lenses and Other Lens Implants
      • Shunts and Other Drainage Devices
    • RESEARCH AND DEVELOPMENT
    • MARKET SIZE AND GROWTH
  • Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
  • Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
    • COMPETITIVE STRUCTURE AND MARKET SHARE
  • Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
  • Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (%)
    • MARKET SUMMARY
      • TOTAL OPHTHALMIC MARKET
  • Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
  • Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($ MILLION)
    • TOTAL MARKET PERCENTAGE DISTRIBUTION BY MARKET SEGMENT
  • Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
  • Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($ MILLION)
  • Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)
    • INDUSTRY PARTICIPANTS BY PRODUCT
  • Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
    • Competitive Analysis
  • Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
• TECHNOLOGY
  • CURRENT USES OF TECHNOLOGY
    • ADVANCED MEDICAL OPTIC' S WAVESCAN/ CUSTOMVUE TECHNOLOGY
    • CRYSTALENS BY EYEONICS, INC.
    • HYBRID LENSES BY SYNERGEYES, INC.
    • SILICONE HYDROGEL
  • Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
    • VISTAKON' S SENOFILCON A LENS
    • VISTAKON' S HIGHLY PERMEABLE LENS TECHNOLOGY
    • IMPLANTABLE CONTACT LENSES (PHAKIC IOL)
    • RETISERT IMPLANT BY BAUSCH & LOMB
    • ORTHOKERATOLOGY
    • NIKE MAXSIGHT
    • TORSIONAL PHACOEMULSIFICATION
    • PATENT EVALUATION BY DRUG
  • Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
  • Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS, 2006-2019
    • PATENT EVALUATION BY TECHNOLOGY
  • Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
    • NEW TECHNOLOGY DEVELOPMENT
• COMPANY PROFILES
  • ADVANCED MEDICAL OPTICS, INC.
  • ALCON LABORATORIES, INC.
  • ALLERGAN, INC.
  • BAUSCH & LOMB INC.
  • CARL ZEISS AG
  • CIBA VISION
  • COOPERVISION, INC.
  • MERCK & CO., INC.
  • NEW WORLD MEDICAL, INC.
  • NIDEK CO., LTD.
  • NOVARTIS INTERNATIONAL, AG
  • PFIZER, INC.
  • STAAR SURGICAL CO.
  • VISTAKON
• APPENDIX: OPHTHALMIC PRODUCT MANUFACTURERS
  • LIST OF OPHTHALMIC PRODUCT MANUFACTURERS
• LIST OF TABLES
  • Summary Table:
  • U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
  • Table 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
  • Table 2 GLAUCOMA TYPES AND KEY POINTS
  • Table 3 KNOWN CAUSES OF UVEITIS
  • Table 4 STRABISMUS TYPES AND RELATED CATEGORIES
  • Table 5 PRODUCTS WITH OCULAR RECALLS 2003-2006
  • Table 6 GOVERNMENT BILLS/LAWS RELATED TO CONTACT LENSES AND THEIR MANUFACTURERS
  • Table 7 SELECTED LEADING OPHTHALMIC MANUFACTURERS/PROVIDERS IN UNITED STATES FOR 2005 ($)
  • Table 8 DRUG COMBINATIONS AND REPORTED SIDE EFFECTS, 2003-2006
  • Table 9 PRODUCT SUMMARY OF OPHTHALMIC ANTI-INFLAMMATORY DRUGS BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 10 PRODUCT SUMMARY OF ANTI-INFECTIVES BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 11 PRODUCTS IN DEVELOPMENT FOR ANTI-INFECTIVES, BY MANUFACTURER AND DEVELOPMENT PHASE, 2006
  • Table 12 PRODUCT SUMMARY OF SELECTED ANTIHISTAMINES AND MAST CELL STABLIZIERS BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 13 PRODUCT SUMMARY OF BETA BLOCKERS BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 14 BETA BLOCKERS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
  • Table 15 PRODUCT SUMMARY OF PROSTAGLANDINS BY MANUFACTURER AND FDA APPROVAL DATE
  • Table 16 PROSTAGLANDINS IN DEVELOPMENT BY MANUFACTURER AND DEVELOPMENT PHASE
  • Table 17 PRODUCT SUMMARY OF OTHER PHARMACEUTICAL TREATMENTS BY MANUFACTURER, PRODUCT TYPE, AND FDA APPROVAL DATE
  • Table 18 OTHER PHARMACEUTICAL PRODUCTS IN DEVELOPMENT FOR OPHTHALMIC CONDITIONS, BY MANUFACTURER AND DEVELOPMENT PHASE
  • Table 19 U.S. MARKET FORECAST FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Table 20 DISTRIBUTION OF REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (PERCENT/$ MILLION)
  • Table 21 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURER REVENUES, 2006 ($ MILLION)
  • Table 22 SELECT CONDITIONS FOUND THROUGH SLIT-LAMP PHOTOGRAPHY
  • Table 23 U.S. MARKET FORECAST FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Table 24 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
  • Table 25 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%/$ MILLION)
  • Table 26 U.S. MARKET FORECAST FOR CONTACT LENSES BY TYPE, THROUGH 2011 ($ MILLION)
  • Table 27 U.S. COMPETITIVE MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
  • Table 28 ENDOSCAPULAR TENSION RINGS AVAILABLE BY MANUFACTURER
  • Table 29 MICROKERATOME/FEMTOSECOND SYSTEMS BY MANUFACTURER
  • Table 30 EXCIMER LASER SYSTEMS BY MANUFACTURER
  • Table 31 SELECT YAG LASER SYSTEMS BY MANUFACTURER
  • Table 32 U.S. MARKET FORECAST FOR OPHTHALMIC SURGICAL EQUIPMENT BY PRODUCT TYPE, THROUGH 2011 ($ MILLION)
  • Table 33 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
  • Table 34 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (PERCENT/$ MILLION)
  • Table 35 TOTAL U.S. OPHTHALMIC MARKET FORECAST, THROUGH 2011 ($ MILLION)
  • Table 36 TOTAL U.S. OPHTHALMIC MARKET FORECAST BY SEGMENT, THROUGH 2011 ($ MILLION)
  • Table 37 U.S. MARKET SUMMARY MARKET LEADERS BY PRODUCT TYPE
  • Table 38 U.S. COMPETITIVE ANALYSIS FOR THE U.S. OPHTHALMIC MARKET BY TOP PROVIDERS AND REVENUES, 2006 (PERCENT/$ MILLION)
  • Table 39 EXTENDED WEAR GAS PERMEABLE SOFT LENSES BY MANUFACTURER
  • Table 40 U.S. DRUG PATENTS FOR OPHTHALMIC CONDITIONS
  • Table 41 NUMBER OF U.S. PATENT EXPIRATIONS BY YEAR FOR OPHTHALMIC DRUGS, 2006-2019
  • Table 42 U.S. OPHTHALMIC PATENT EVALUATION BY MAJOR TECHNOLOGY
• LIST OF FIGURES
  • Summary Figure:
  • U.S. OPHTHALMIC MARKET ANALYSIS BY SEGMENT, 2004-2011 ($ MILLION)
  • Figure 1 U.S. INCIDENCE AND PREVALENCE OF SELECTED EYE CONDITIONS AND DISEASES
  • Figure 2 U.S. MARKET FOR OPHTHALMIC PHARMACEUTICALS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Figure 3 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC PHARMACEUTICALS BY CONDITION, 2006 (%)
  • Figure 4 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC PHARMACEUTICALS BY MANUFACTURERS REVENUES, 2006 (%)
  • Figure 5 U.S. MARKET FOR OPHTHALMIC DIAGNOSTICS BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Figure 6 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC DIAGNOSTICS BY CONDITION, 2006 (%)
  • Figure 7 COMPETITIVE U.S. MARKET SHARE FOR OPHTHALMIC DIAGNOSTICS BY MANUFACTURERS REVENUES, 2006 (%)
  • Figure 8 U.S. MARKET FOR CONTACT LENSES BY TYPE, 2004-2011 ($ MILLION)
  • Figure 9 COMPETITIVE U.S. MARKET SHARE FOR CONTACT LENSES BY MANUFACTURERS REVENUES, 2006 (%)
  • Figure 10 U.S. MARKET FOR SURGICAL EQUIPMENT BY PRODUCT TYPE, 2004-2011 ($ MILLION)
  • Figure 11 DISTRIBUTION OF U.S. REVENUES FOR OPHTHALMIC SURGICAL EQUIPMENT BY CONDITION, 2006 (%)
  • Figure 12 COMPETITIVE U.S. MARKET SHARE FOR SURGICAL EQUIPMENT BY MANUFACTURERS REVENUES, 2006 (%)
  • Figure 13 TOTAL U.S. OPHTHALMIC MARKET FORECAST, 2004-2006, AND 2011 ($ MILLION)
  • Figure 14 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 ($ MILLION)
  • Figure 15 U.S. MARKET SUMMARY TOTAL OPHTHALMIC MARKET, 2004-2011 (%)

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

全球眼科處理數量資料庫

Global Ophthalmology Procedure Volumes Database

價格 : US $ 5000

BCC Research發行的製藥相關市場調查報告書

全球的肝臟疾病治療藥市場

Liver Disease Treatments: The Global Market

價格 : US $ 4850

出版日期 : 2012年01月

2011年醫療市場調査評論

2011 Healthcare Research Review

價格 : US $ 850

出版日期 : 2012年01月

肺部給藥系統:技術和全球市場

Pulmonary Drug Delivery Systems: Technologies and Global Markets

價格 : US $ 4850

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!